Protective effect of ischemic preconditioning on liver preservation- reperfusion injury in rats

Transplantation

Volumn 66, Issue 2, 1998, Pages 152-157

  Yin, Deng Ping ^a   Sankary, Howard N ^a   Chong, Anita S F ^a   Ma, Lian L I ^a   Shen, Jikun ^a   Foster, Preston ^a   Williams, James W ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EURO COLLINS SOLUTION; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; HEPATIC ARTERY; LIVER FUNCTION; LIVER PERFUSION; LIVER PRESERVATION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURVIVAL RATE; SURVIVAL TIME;

ANIMALS; COLD; GRAFT SURVIVAL; ISCHEMIC PRECONDITIONING; LIVER; LIVER TRANSPLANTATION; MALE; NITRIC OXIDE; ORGAN PRESERVATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032558159     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199807270-00002     Document Type: Article

References (26)

1. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation: a multivariate analysis. Transplantation 1993; 55: 807.
2. Jaeschke H. Preservation injury: mechanisms, prevention and consequences. J Hepatol 1996; 25: 774.
3. Sankary HN, Foster P, Brown E, Williams J. A comparison of Collins and UW solution for cold ischemic preservation of the rat liver. J Surg Res 1991; 51: 87.
4. Sheron N, Eddleston A. Preservation-reperfusion injury, primary graft non-function and tumor necrosis factor. J Hepatol 1992; 16: 262.
5. Meldrum DR, Mitchell MB, Banerjee A, Harken A. Cardiac preconditioning: induction of endogenous tolerance to ischemia-reperfusion injury. Arch Surg 1993; 128: 1208.
6. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124.
7. Zhang B, Borderie D, Sogni P, Soubrane O, Houssin D, Calmus Y. NO-Mediated vasodilation in the rat liver: role of hepatocytes and liver endothelial cells. J Hepatol 1997; 26: 1348.
8. Hardy KJ, McClure DN, Subwongcharoen S. Ischemic preconditioning of the liver: a preliminary study. Aust N Z J Surg 1996; 66: 707.
9. Peralta C, Hotter G, Closa D, Gelpi E, Bulbena O, Rosello-Catafau J. Protective effect of preconditioning in the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 1997; 25: 934.
10. Vos TA, Gouw ASH, Klok PA, et al. Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats. Gastroenterology 1997; 113: 1323.
11. Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1b-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 1997; 185: 601.
12. Kamada N. The immunology of experimental liver transplantation in the rat. Immunology 1985; 55: 369.
13. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986; 99: 105.
14. Eskandari MK, Nguyen DT, Kunkel SL, Remick DG. WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability. Immunol Invest 1990; 19: 69.
15. Koeppel TA, Thies JC, Schemmer P, et al. Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow. J Hepatol 1997; 27: 163.
16. Gao W, Washington MK, Bentley RC, Clavien PA. Antiangiogenic agents protect liver sinusoidal lining cells from cold preservation injury in rat liver transplantation. Gastroenterology 1997; 113: 1692.
17. Saavedra JE, Billiar TR, Williams D, Kim YM, Watkins SC, Keefer LK. Targeting nitric oxide (NO) delivery in vivo: design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-α-induced apoptosis and toxicity in the liver. J Med Chem 1997; 40: 1947.
18. Kim YM, de Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factora-reduced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997; 272: 1402.
19. Shiraishi M, Hiroyasu S, Nagahama M, et al. Role of exogenous L-arginine in hepatic ischemia-reperfusion injury. J Surg Res 1997; 69: 429.
20. Downey JM, Liu GS, Thornton JD. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res 1993; 27: 3.
21. Sankary HN, Chong A, Foster P, et al. Inactivation of Kupffer cells after prolonged donor fasting improves viability of transplanted hepatic allografts. Hepatology 1995; 22: 1236.
22. Sankary HN, Chong A, Foster P, Brown E, Williams J. Improved viability of hepatic allografts from fasted donors is associated with decreased peripheral TNF activity. J Surg Res 1995; 58: 337.
23. Suzuki S, Nakamura S, Sakaguchi T, et al. Alteration of reticuloendothelial phagocytic function and tumor necrosis factor-α production after total hepatic ischemia. Transplantation 1997; 64: 821.
24. Colletti LM, Remick DG, Burtch GD, et al. Role of tumor necroses factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 1936.
25. Sankary HN, Foster P, Brown E, Williams J. Do splanchnic viscera contribute to liver preservation reperfusion injury? Transplantation 1996; 61: 1142.
26. Jenkins DP, Baxter GF, Yellon DM. The pathophysiology of ischemic preconditioning. Pharmacol Res 1995; 31: 219.